Mednet Member
Neurology · Greater Boston Headache Center at Boston Advanced Medicine
Eptinezumab (Vyepti) in a dose of 100 or 300 mg. It is a CGRP antibody marketed for the preventive treatment of episodic or chronic migraine. However, in a randomized, double-blinded, placebo-controlled trial treating patients with 100 mg IV for moderate or severe migraine headache, it met the FDA-d...
Mednet Member
Neurology · Quinnipiac Netter School of Medicine
In Addition to Vyepi infusion or other CGRP inhibitors injection, the following are possible:
- IV Metoclopromide 10 mg
- IV Benadryl 50 mg
- IV Depacon 500 mg can be repeated in 1- 2 hours
- IV Decadron 10 mg
- IV Magnesium Sulfate 1 gram
- Ketorolac 60 mg IV or IM if no GI or NSAIDs allergy contraindications...